Does Nattokinase Help With Erectile Dysfunction?

No clinical trial has tested nattokinase specifically for erectile dysfunction, so there is currently no direct evidence that it helps. The supplement does have documented effects on blood vessel health, blood pressure, and clot breakdown, and since many cases of ED stem from vascular problems, the theoretical link makes intuitive sense. But a plausible mechanism and actual proof of benefit are very different things, and right now nattokinase sits firmly in the “plausible but unproven” category when it comes to erections.

Why People Connect Nattokinase to ED

Nattokinase is a protein-digesting enzyme produced during the fermentation of soybeans into natto, a traditional Japanese food. It has been studied primarily for cardiovascular applications. Research shows it has fibrinolytic activity, meaning it helps break down fibrin, a protein involved in blood clot formation. It also appears to lower blood pressure, reduce atherosclerotic plaque, and improve lipid profiles.¹ Large-scale clinical trials have confirmed that nattokinase significantly improves lipid profiles and reduces atherosclerotic plaque area and the thickness of artery walls.²

The leap to erectile dysfunction goes like this: erections depend on healthy blood flow into the penis, vascular disease impairs that blood flow, and nattokinase improves vascular health, so maybe it improves erections too. This chain of reasoning is not crazy. It is roughly the same logic that led researchers to discover that drugs originally developed for heart conditions could treat ED. But each link in the chain needs its own evidence, and the final link, nattokinase actually improving erectile function in men, has never been studied.

The Vascular Roots of Erectile Dysfunction

To understand why the nattokinase-ED connection is tempting but premature, it helps to know how central blood vessel health is to erections. Penile erection requires a rapid increase in blood flow to the erectile tissue, driven largely by relaxation of smooth muscle in the penile arteries. That relaxation depends on a healthy endothelium, the thin layer of cells lining blood vessels that produces nitric oxide and other signaling molecules. When the endothelium is damaged by high blood pressure, high cholesterol, diabetes, or metabolic syndrome, the vasodilation response weakens and blood flow suffers.³

Research using non-invasive measurements of endothelial function has confirmed just how stark this difference is. In one study, men with vascular ED showed dramatically lower endothelial function scores compared to both men with non-vascular ED and healthy controls, while the non-vascular ED group looked essentially normal.⁴ In other words, when ED has a vascular cause, the endothelial impairment is measurable and significant. This is what makes the vascular angle so important and why supplements claiming to improve blood vessel function get attention from men dealing with ED.

ED as an Early Warning for Heart Disease

The connection between erectile dysfunction and cardiovascular health runs deeper than many people realize. Researchers have described ED as a potential early marker for atherosclerosis and cardiovascular disease, arguing that diagnosing ED could become a clinical tool for early detection of broader vascular problems.⁵ The reason is anatomical: the arteries supplying the penis are smaller than coronary arteries, so they tend to show the effects of atherosclerosis earlier. A man might develop erectile difficulties years before a blocked coronary artery causes chest pain or a heart attack.

This is not just theoretical. Research on human tissue has shown that penile blood vessels exhibit age-related impairment in endothelium-dependent vasodilation earlier than larger vessels like the aorta or mesenteric arteries. Significant impairment in penile vasculature was detected in men over 55, while comparable impairment in other vascular beds did not appear until after 65.⁶ This functional vulnerability of penile blood vessels to aging helps explain why ED so often precedes broader cardiovascular symptoms.

For the nattokinase question, this relationship cuts both ways. On one hand, it strengthens the theoretical case: if ED and cardiovascular disease share vascular roots, then something that genuinely improves cardiovascular health might eventually help erectile function too. On the other hand, it raises the stakes. A man experiencing ED may have early-stage cardiovascular disease that deserves medical evaluation, not just a supplement.

What Nattokinase Actually Does in the Body

The cardiovascular effects of nattokinase are better established than most supplement claims, though they still have limits. After you take nattokinase orally, it is absorbed and shows measurable activity in the bloodstream. A study using 2,000 fibrinolytic units found increased fibrinolysis and anticoagulant activity between two and eight hours after intake, consistent with earlier bioavailability data showing serum activity lasting up to 24 hours.⁷ So the enzyme does survive digestion and reach the bloodstream in active form, which is not a given for protein-based supplements.

Its primary documented action is breaking down fibrin, the structural protein in blood clots. Beyond that, laboratory and animal research has identified several additional effects. Peptides released during nattokinase digestion show the ability to inhibit angiotensin-converting enzyme (ACE), the same target that ACE-inhibitor blood pressure medications go after.⁸ In mice fed a high-cholesterol diet, natto consumption significantly reduced atherosclerotic lesions in the aorta compared to mice that did not eat natto, though the researchers noted that this effect did not follow a consistent pattern with changes in blood lipid levels.⁹

None of these effects are trivial. Clot dissolution, blood pressure reduction, and slowed plaque progression are all meaningful for cardiovascular health. The gap is that none of them have been shown to translate into improved erectile function. The penile vasculature is a specific vascular bed with its own physiology, and general vascular improvement does not automatically mean the right kind of improvement in the right place at the right time to produce better erections.

Why Vascular Benefits Do Not Automatically Fix Erections

This is where the reasoning gets tricky. Erections require a specific sequence of events: sexual arousal triggers nerve signals, which cause endothelial cells in the penile arteries to produce nitric oxide, which relaxes smooth muscle, which allows blood to rush in and engorge the erectile tissue. Damage to any point in that chain can cause ED. Vascular disease tends to impair the endothelial step, reducing nitric oxide production and making it harder for arteries to dilate on demand.

Nattokinase’s documented effects, breaking down fibrin, lowering blood pressure, and reducing plaque, operate upstream of the nitric oxide signaling that erections depend on. A cleaner, less clogged artery is better than a clogged one, but the endothelial dysfunction that underlies vascular ED involves damage to the cells themselves and their ability to produce nitric oxide when stimulated. Reducing plaque does not necessarily restore that cellular signaling capacity, at least not quickly or directly. This is a distinction that gets lost when people reason from “good for blood vessels” to “good for erections.”

Consider the analogy of a garden hose. Nattokinase might help clear mineral deposits from the interior walls, but if the valve mechanism at the nozzle is stuck, you still do not get the burst of water flow you need. Erectile function depends on rapid, on-demand vasodilation, not just long-term arterial health. This does not mean long-term vascular improvement is irrelevant, but it does mean that taking nattokinase and expecting noticeable improvement in erections within days or weeks, as many supplement marketing claims imply, is not supported by any known mechanism.

Safety Considerations and Drug Interactions

Even setting aside whether nattokinase helps with ED, anyone considering it should be aware of its interaction profile. Because nattokinase enhances fibrinolysis and has anticoagulant effects, it carries a real bleeding risk, particularly for people already taking blood-thinning medications like warfarin, aspirin, or direct oral anticoagulants. A review of anti-atherosclerotic supplements including nattokinase noted that their clinical effectiveness depends on formulation, dosage, and patient characteristics, and may be limited by bleeding risk or drug interactions.¹⁰

This is particularly relevant for men with ED who also have cardiovascular risk factors, which is a large group given the overlap between the two conditions. These men are often already on antiplatelet or anticoagulant therapy, statins, or blood pressure medications. Adding nattokinase without medical guidance could create dangerous interactions. If you are taking any prescription medication for cardiovascular health, talk to your doctor before adding nattokinase.

The supplement is generally considered safe in healthy adults at typical doses of around 2,000 fibrinolytic units per day, but “generally safe” and “safe for you specifically” are different claims, especially when other medications are in the mix.

Supplements That Do Have Some ED Evidence

If you are looking for supplements with actual clinical data supporting their use in erectile dysfunction, a few candidates have more direct evidence than nattokinase, though none are miracle cures.

L-citrulline, an amino acid found in watermelon, gets converted to L-arginine in the body, which in turn is the raw material for nitric oxide production. In a small trial of men with mild ED, half of those taking L-citrulline saw their erection hardness improve from mild ED to normal function, compared to about 8% of those on placebo. Their average number of intercourses per month also roughly doubled during the treatment phase.¹¹ The study was small, with 24 men, so these numbers should be taken with caution, but the results were statistically significant and the mechanism is well understood.

Another combination that has attracted research attention is L-arginine paired with Pycnogenol, a pine bark extract. A randomized, placebo-controlled crossover trial found that one month of this combination restored erectile function to normal in men with mild to moderate ED, doubled intercourse frequency, and significantly increased both nitric oxide synthase activity and testosterone levels.¹² A systematic review and meta-analysis of this combination concluded that it may have a significant effect on improving sexual function in patients with mild to moderate ED.¹³

The key difference between these supplements and nattokinase is that L-citrulline and L-arginine act directly on the nitric oxide pathway that erections depend on. They provide the biochemical substrate that endothelial cells use to make nitric oxide. Nattokinase, by contrast, works on clotting, blood pressure, and plaque, which are related to but not the same as the nitric oxide signaling mechanism that drives erections. This does not make nattokinase useless for vascular health, but it does explain why the supplements with more direct ED evidence tend to be ones that target the nitric oxide pathway specifically.

The Marketing Problem

Nattokinase has become popular in online health communities, and it is often promoted alongside claims about dissolving “spike proteins,” clearing arteries, and improving circulation in ways that naturally extend to sexual health claims. The supplement industry is not required to prove that a product treats a specific condition before selling it, only that it is generally safe. This creates a landscape where theoretical benefits are presented as established facts, and where the absence of negative evidence (“no study has shown it doesn’t work”) gets spun as positive evidence.

The honest picture is more nuanced. Nattokinase has real cardiovascular research behind it, more than many supplements can claim. Its fibrinolytic and blood-pressure-lowering effects are supported by clinical data. But “supports cardiovascular health” is not the same as “treats erectile dysfunction,” and the jump from one to the other requires studies that simply have not been done. If you are considering nattokinase for ED specifically, you are essentially betting on a hypothesis, not acting on evidence.

When to See a Doctor Instead

Given that ED can be an early signal of cardiovascular disease, sometimes appearing years before a cardiac event, treating it as purely a bedroom problem and reaching for supplements may mean missing something important. Men who develop ED, particularly those in their 40s and 50s without an obvious psychological cause, should consider a cardiovascular evaluation. Blood pressure, cholesterol, fasting glucose, and other standard markers can reveal risk factors that are far more effectively managed with proven medical therapies than with supplements.

Prescription PDE5 inhibitors remain the first-line treatment for ED and work by amplifying the nitric oxide signal in penile tissue. They are effective for the majority of men with vascular ED, and they have decades of safety data behind them. For men who cannot tolerate these medications or who prefer a more supplement-based approach, the nitric-oxide-pathway supplements discussed earlier at least have preliminary clinical trial data specific to ED. Nattokinase may have a role in long-term vascular maintenance, but relying on it as an ED treatment when alternatives with direct evidence exist means choosing hope over data.

The Penile Vasculature Ages Faster Than You Think

One of the more striking findings in recent vascular research is how early penile blood vessels start to show age-related decline compared to other parts of the circulatory system. As mentioned earlier, significant impairment in penile vasodilation appeared in men over 55, while comparable dysfunction in mesenteric and aortic vessels did not show up until after 65.⁶ This roughly ten-year head start in penile vascular aging underscores why ED appears before other cardiovascular symptoms and why the small arteries of the penis are so sensitive to anything that impairs endothelial function.

This finding also raises an interesting question for the nattokinase discussion. If penile vasculature ages faster, it may also be harder to rescue with generalized vascular interventions. The damage may be more advanced in penile arteries than in the rest of the body by the time a man notices symptoms. A supplement that modestly improves systemic vascular health might make a measurable difference in larger vessels while doing very little for the smaller, more damaged penile vasculature. This is speculative, but it aligns with the broader point that vascular ED requires targeted interventions, not just general circulatory support. Until someone designs a trial that actually measures erectile outcomes in men taking nattokinase, we are left guessing about whether its benefits extend to the specific vascular bed that matters most for this particular problem.